Last updated on August 2018

Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02


Brief description of study

This study will evaluate the safety and efficacy of Relamorelin compared to placebo in patients with diabetic gastroparesis. Patients will report daily severity scores of their diabetic gastroparesis symptoms.

Clinical Study Identifier: NCT03426345

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Registry Team

Klinische Forschung Karlsruhe GmbH
Karlsruhe, Germany
  Connect »